CureVac’s RNAntibody back
The publication in EMBO Molecular Medicine demonstrates CureVac’s proprietary mRNA technology enables antibody mediated therapies against infectious agents, toxins and tumors
scienceDISPLAY Dr. Bettina Danker update: 12.09.2024 Impressum Privacy/Datenschutz
